Prostate Cancer: What Is the Evidence for Dietary Restrictions? (As of 2026)

The available materials do not describe specific foods to avoid or dietary restrictions for prostate cancer patients, so this particular question cannot be answered with a sourced basis. However, the materials do cover the factors used to determine diagnosis and treatment direction, as well as the standard approach at each stage of treatment.

Key Summary

• The available materials on prostate cancer do not include any explanation of foods to avoid or dietary restrictions, so this question cannot be answered with a sourced basis.
• Prostate cancer is a cancer in which treatment is determined by a risk group that combines PSA level, Gleason score (grade group 1 through 5), and stage.
• Korea's 5-year relative survival rate for prostate cancer is 96.9% (National Cancer Registration Statistics 2019–2023, National Cancer Center Korea Central Cancer Registry).
• Low-risk prostate cancer is one of the rare cancers for which active surveillance—monitoring at set intervals without treatment—is a standard option.
• For patients undergoing hormone therapy, changes such as decreased bone density, muscle loss, and increased body fat are common, and it is generally recommended to combine exercise with bone density testing to manage these changes.

Are there specific foods prostate cancer patients should avoid?

• The available materials do not contain specific content regarding dietary restrictions or foods to avoid for prostate cancer patients. Therefore, we are unable to provide a sourced basis for claims that certain foods should or should not be eaten.
• The materials do explain that patients undergoing hormone therapy may experience hot flashes, decreased libido, fatigue, muscle loss combined with increased body fat, and decreased bone density, and note that it is common to manage these changes through exercise and bone density testing. This is a matter of general lifestyle management, distinct from prohibiting specific foods.
• For specific dietary guidance, it is best to consult with the medical team who understands the stage of treatment (surgery, radiation therapy, hormone therapy) and the individual's health status.

What should be managed at each stage of treatment?

• Stage 1, for low-risk disease, active surveillance—monitoring at set intervals using PSA, MRI, and repeat biopsy as needed—is the standard approach. At this stage, keeping to the testing schedule is more important than any specific dietary restriction.
• Stage 2, for patients undergoing surgery (robotic radical prostatectomy), hospitalization typically lasts 5 to 7 days, followed by pelvic floor exercises for urinary incontinence recovery, with overall recovery generally taking several months.
• Stage 3, during radiation therapy or particle therapy, frequent urination, burning sensation, and changes in bowel habits are common and typically subside over several weeks after treatment ends.
• Stage 4, for patients undergoing hormone therapy, decreased bone density and changes in muscle and body fat are recommended to be managed through exercise and bone density testing—this falls under overall lifestyle management rather than diet.
• Stage 5, in the metastatic stage when chemotherapy is combined with treatment, fatigue, decreased blood counts, and numbness in the hands and feet may occur with each cycle, making overall condition management during this period important.

FAQ — Is weight or muscle change during hormone therapy related to diet?

Hormone therapy works by blocking male hormones, and its effects can include muscle loss combined with increased body fat and decreased bone density. These changes are not caused by eating or avoiding particular foods, but are explained as a systemic effect of hormone suppression itself. The general approach to managing these changes is to combine exercise with regular bone density testing.

FAQ — Survival rates are high, so does lifestyle management really matter?

Korea's 5-year relative survival rate for prostate cancer is 96.9% (National Cancer Registration Statistics 2019–2023, National Cancer Center Korea Central Cancer Registry), but this is a nationwide average figure, not a predictor of any individual's outcome. Actual course of disease varies significantly depending on risk group, stage, and age, so managing side effects at each treatment stage (such as incontinence recovery exercises and bone density management) should be determined together with the medical team based on the individual's condition.

Sources and Notes

• This article was written based on National Cancer Registration Statistics 2019–2023 (National Cancer Center Korea Central Cancer Registry), the National Cancer Information Center, and NCCN patient guidelines. Specific information on dietary restrictions or prohibited foods for prostate cancer patients was not included in the available materials and has therefore been excluded from this answer.
• This content is intended for general medical information purposes, and diagnosis, treatment methods, and outcomes may vary depending on individual circumstances. Accurate diagnosis and treatment should always be determined through consultation with your medical team.